Drug Shortage Report for TARO-DEFERASIROX

Last updated on 2020-02-02 History
Report ID 101327
Drug Identification Number 02463547
Brand name TARO-DEFERASIROX
Common or Proper name DEFERASIROX
Company Name TARO PHARMACEUTICALS INC
Market Status MARKETED
Active Ingredient(s) DEFERASIROX
Strength(s) 500MG
Dosage form(s) TABLET FOR SUSPENSION
Route of administration ORAL
Packaging size 30
ATC code V03AC
ATC description ALL OTHER THERAPEUTIC PRODUCTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-11-26
Estimated end date 2020-06-30
Actual end date 2020-01-31
Shortage status Resolved
Updated date 2020-02-02
Company comments Discontinued
Health Canada comments
Contact Address 130 EAST DRIVE
BRAMPTON, ONTARIO
CANADA L6T 1C1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2020-02-02 French Compare
v3 2020-02-02 English Compare
v2 2019-12-13 French Compare
v1 2019-12-13 English Compare